These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9710045)

  • 1. Inclusion body myositis in twins.
    Amato AA; Shebert RT
    Neurology; 1998 Aug; 51(2):598-600. PubMed ID: 9710045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion body myositis (IBM).
    Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
    Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial inflammatory inclusion body myositis.
    Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
    Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
    Sivakumar K; Semino-Mora C; Dalakas MC
    Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.
    Sanmaneechai O; Swenson A; Gerke AK; Moore SA; Shy ME
    Neuromuscul Disord; 2015 Apr; 25(4):297-300. PubMed ID: 25599912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
    Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
    Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews.
    Sivakumar K; Dalakas MC
    Neurology; 1996 Oct; 47(4):977-84. PubMed ID: 8857730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM.
    Vasconcelos OM; Raju R; Dalakas MC
    Neurology; 2002 Dec; 59(11):1776-9. PubMed ID: 12473769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
    Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-sensitive hereditary inclusion body myositis.
    Naumann M; Reichmann H; Goebel HH; Moll C; Toyka KV
    J Neurol; 1996 Feb; 243(2):126-30. PubMed ID: 8750548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies.
    Koffman BM; Sivakumar K; Simonis T; Stroncek D; Dalakas MC
    J Neuroimmunol; 1998 Apr; 84(2):139-42. PubMed ID: 9628455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion body myositis: from genetics to clinical trials.
    Nagy S; Khan A; Machado PM; Houlden H
    J Neurol; 2023 Mar; 270(3):1787-1797. PubMed ID: 36399165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
    Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary inclusion-body myopathy].
    Kucharz EJ
    Przegl Lek; 1999; 56(11):735-8. PubMed ID: 10800587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
    Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
    Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
    Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
    J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.